Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPCC
3601
DELISTED
Infinity Property & Casualty C
IPCC
| $1.84M | ﹤0.01% |
17,339
+7,310
| +73% | +$743K |
|
3602
CALL
Gray Television
GTN
$538M
| $1.84M | ﹤0.01% |
109,700
+77,000
| +235% | +$1.2M |
|
3603
CALL
Myriad Genetics
MYGN
$290M
| $1.84M | ﹤0.01% |
53,500
+19,800
| +59% | +$668K |
|
3604
CALL
Universal Health Services
UHS
$10B
| $1.84M | ﹤0.01% |
16,200
-7,700
| -32% | -$823K |
|
3605
PUT
Ryanair
RYAAY
$30.5B
| $1.83M | ﹤0.01% |
44,000
+7,500
| +21% | +$334K |
|
3606
iShares GNMA Bond ETF
GNMA
$432M
| $1.83M | ﹤0.01% |
+37,021
| New | +$1.84M |
|
3607
Hudbay
HBM
$11.9B
| $1.83M | ﹤0.01% |
208,200
+178,125
| +592% | +$1.39M |
|
3608
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $1.83M | ﹤0.01% |
40,832
-70,476
| -63% | -$3M |
|
|
FPRX
3609
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.83M | ﹤0.01% |
+83,284
| New | +$2.68M |
|
|
DCOM
3610
DELISTED
Dime Community Bancshares
DCOM
| $1.83M | ﹤0.01% |
87,161
+29,068
| +50% | +$622K |
|
3611
Cerus
CERS
$601M
| $1.82M | ﹤0.01% |
539,948
-393,141
| -42% | -$1.33M |
|
3612
A10 Networks
ATEN
$1.99B
| $1.82M | ﹤0.01% |
236,082
-165,531
| -41% | -$1.26M |
|
|
GREK
3613
PUT
Global X MSCI Greece ETF
GREK
$334M
| $1.82M | ﹤0.01% |
59,067
+38,700
| +190% | +$1.09M |
|
3614
Fidelity High Dividend ETF
FDVV
$10.5B
| $1.82M | ﹤0.01% |
+63,431
| New | +$1.77M |
|
3615
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
| $1.82M | ﹤0.01% |
40,508
+33,492
| +477% | +$1.5M |
|
|
QTNA
3616
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $1.82M | ﹤0.01% |
149,001
+106,255
| +249% | +$1.45M |
|
3617
CALL
Agilent Technologies
A
$41.9B
| $1.81M | ﹤0.01% |
27,100
-16,700
| -38% | -$1.13M |
|
3618
Houlihan Lokey
HLI
$8.99B
| $1.81M | ﹤0.01% |
+39,914
| New | +$1.71M |
|
3619
Invesco Preferred ETF
PGX
$3.77B
| $1.81M | ﹤0.01% |
+121,879
| New | +$1.83M |
|
3620
PUT
HDFC Bank
HDB
$120B
| $1.81M | ﹤0.01% |
71,200
+32,400
| +84% | +$776K |
|
|
CNCE
3621
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.81M | ﹤0.01% |
69,961
-54,718
| -44% | -$1.1M |
|
3622
PUT
Acadia Pharmaceuticals
ACAD
$4.87B
| $1.81M | ﹤0.01% |
60,000
+20,500
| +52% | +$656K |
|
3623
CBRE Group
CBRE
$44.3B
| $1.81M | ﹤0.01% |
41,689
-922,462
| -96% | -$38.2M |
|
|
P
3624
PUT
Everpure Inc
P
$39.3B
| $1.81M | ﹤0.01% |
113,900
+81,400
| +250% | +$1.36M |
|
3625
CALL
Direxion Daily Technology Bull 3x ETF
TECL
$6.39B
| $1.81M | ﹤0.01% |
161,000
+86,000
| +115% | +$916K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.